Patient Power®
Get Email Alerts!
Health Topics
Lymphoma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    Spring Survey 2012 Results

    Emerging Treatments in Follicular Lymphoma

    PROGRAM DETAILS:

    This is a very provocative lymphoma discussion with a leading expert, Dr. Jonathan Friedberg from James P. Wilmot Cancer Center. Dr. Friedberg addresses some of today's most compelling questions for lymphoma patients and their doctors. When should treatment begin? Where does Rituxan fit in, and should it be used as a "maintenance" therapy? Could radioimmunotherapy be used more widely? Are new chemotherapy agents expected to be approved? Do new drugs like Velcade and Revlimid have a place in lymphoma care? Are there new types of agents like BCL-2 inhibitors that could make a difference? What results are expected with the lymphoma vaccine trials?

    Dr. Friedberg begins by discussing the basics of follicular lymphoma including diagnosis, signs and symptoms, the various stages and treatments. He speaks at length about the promise that radioimmunotherapy shows for the future and agents that have been underutilized. Dr. Friedberg also addresses new chemotherapy agents such as Revlamid and older agents like Bendamustine that are beginning to resurface. You’ll also hear about the new class of proteasome inhibitors, like Velcade, how they work and how they are changing treatment for Lymphoma.

    In this program you’ll learn more about clinical trials and the future for lymphoma treatment. Dr. Friedberg discusses why every Lymphoma is different, which is why it’s so important to partner with your doctor to take an individualized approach to your treatment. Also hear answers to questions from listeners just like you.

    Get Email Updates:

    Get updated automatically when new content about Lymphoma has been posted.
    Privacy Policy
    Lymphoma
    EXPERTS & GUESTS:
    Jonathan Friedberg, M.D.
    Hematologist, James P. Wilmot Cancer Center, University of Rochester Medical Center
    more >

    TRANSCRIPT:

    1. Introduction
    2. Diagnosing Follicular Lymphoma
    3. Emerging Approaches for Treating Follicular Lymphoma
    4. When to Start Treatment for Follicular Lymphoma
    5. Formulating a Treatment Plan
    6. Existing and Emerging Treatments
    7. Keeping Follicular Lymphoma in Remission
    8. Rituxan as a Humanized Monoclonal Antibody
    9. Repeating Rituxan Therapy After Remission and Discussion on Maintenance Rituxan
    10. Treatment Options After Becoming Rituxan Resistant
    11. Radioimmunotherapy
    12. Benefits of Rituxan Therapy
    13. Stem Cell Transplants and Future Options
    14. Signs and Symptoms of Follicular Lymphoma and Staging
    15. Chemotherapy Effects on Fertility
    16. CVP Versus Rituxan
    17. Researching Recurrence of Follicular Lymphoma
    18. Prognostic Markers in Follicular Lymphoma
    19. Upcoming Information on Follicular Lymphoma
    20. Future Treatments for Follicular Lymphoma
    21. Partnering with Your Physician

    RELATED LINKS: